When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TEVA - Aquestive launches early-stage study of sublingual epinephrine for allergic reactions
Teva Pharmaceutical Industries Limited American Depositary Shares
Aquestive Therapeutics (NASDAQ:AQST)initiates a Phase 1 clinical trial in 28 healthy volunteers evaluating the safety and pharmacokinetics (PK) of AQST-108, an oral sublingual formulation of epinephrine, for the potential treatment of allergic reactions, including anaphylaxis (acute allergic reactions).
More news on: Aquestive Therapeutics, Inc., Mylan N.V., Amphastar Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,